US Stock MarketDetailed Quotes

TMDX TransMedics

Watchlist
  • 92.080
  • +2.830+3.17%
Close Apr 26 16:00 ET
  • 92.110
  • +0.030+0.03%
Post 19:47 ET
3.02BMarket Cap-119584P/E (TTM)

About TransMedics Company

TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform. It focuses on the preservation of human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA.

Company Profile

SymbolTMDX
Company NameTransMedics
Listing DateMay 2, 2019
Issue Price16.00
Founded1998
CEODr. Waleed Hassanein, M.D.
MarketNASDAQ
Employees584
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address200 Minuteman Road,Suite 302
CityAndover
ProvinceMassachusetts
CountryUnited States of America
Zip Code01810
Phone1-978-552-0900
Websitehttp://www.transmedics.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Waleed Hassanein, M.D.
  • President, Chief Executive Officer and Director
  • 6.76M
  • Dr. Tamer Khayal, M.D.
  • Chief Commercial Officer
  • 2.63M
  • Stephen Gordon
  • Chief Financial Officer and Treasurer
  • 2.64M
  • Nick Corcoran
  • Senior Vice President, Supply Chain and Operations
  • 2.52M
  • Anil P. Ranganath
  • Senior Vice President, General Counsel and Corporate Secretary
  • 2.19M
  • James R. Tobin
  • Chairman of the Board
  • 262.32K
  • Dr. David Weill, M.D.
  • Independent Director
  • 222.78K
  • Thomas J. Gunderson
  • Independent Director
  • 237.74K
  • Edwin M. Kania, Jr.
  • Independent Director
  • 220.28K
  • Edward M. Basile
  • Independent Director
  • 232.26K
  • Merilee Raines
  • Independent Director
  • 238.62K
  • Stephanie Lovell
  • Independent Director
  • 219.79K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg